REGISTER
OCC 2026 | Bringing Heart Failure Care Home
The conversation turns to the transition from hospital-based heart failure treatment to community and home-based management. Prof. Chun Liang highlights wearable devices as tools for monitoring symptoms and early warning signals, helping connect patients, family doctors, and specialists for earlier intervention.

In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Heart Failure · Rebirth: Making the Broken Heart Beat Again”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and co-moderated by Prof. Xuanxuan Li, Shi Jia Zhuang Great Wall Hospital. Quest for Truth is honored to welcome two distinguished interview guests: Dr. Nazha Hamdani, Ruhr-Universität Bochum; and Prof. Chun Liang, Shanghai Changzheng Hospital.

In this segment, the discussion turns from hospital-based treatment to community and home-based heart failure management. Prof. Gang Wu asks Prof. Chun Liang what the key breakthrough should be in screening, diagnosis, and follow-up models, and what remains the most difficult link between hospital care and community care.

Prof. Chun Liang reflects on the evolution of heart failure treatment, from traditional staged management to newer therapeutic strategies that include SGLT2 inhibitors and GLP-1 receptor agonists for selected patients. He agrees with Dr. Nazha Hamdani that prevention must begin earlier, before patients progress into more advanced heart failure.

Looking ahead, Prof. Liang highlights wearable devices as a promising tool for monitoring patients outside the hospital. By tracking symptoms and early warning signals at home, wearable technology may help patients seek timely support from family doctors or specialists, enabling earlier intervention, more intensive therapy when needed, and a stronger connection between hospital-based expertise and community-level care.

0
0
Loading